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December 1, 2008 was a Red Letter Day for 
Jefferson’s new School of Population Health:  The 
University Board of Trustees ratified the School’s 
bylaws, appointed David B. Nash, MD, MBA as the 
Founding Dean, and approved two new Master 
of Science degree programs in Health Policy 
and Healthcare Quality and Safety. These new 
programs and the current Master of Public Health 
(MPH) constitute the School’s inaugural academic 
offerings. With students slated to begin classes 
this September, these programs could not have 
come at a more crucial time:  the cost of health 
care continues to rise, access is absent for many 
Americans, and troubling issues around quality  
and safety populate the daily headlines. Never  
has the preparation of leaders to guide health 
care and public health been more urgent. 
The mission of Jefferson School of Population 
Health is to find solutions to the nation’s healthcare 
ills and to produce the leaders and the research 
that will make this happen. In keeping with this 
challenge, the School has designed unique and 
pioneering educational programs to prepare 
leaders who will make a difference—a world of 
difference—in the future of American health 
and healthcare. 
The School’s Master of Science in Health Policy 
(MS-HP) prepares leaders to critically analyze 
the organization, financing, and delivery of health 
care; to rigorously apply analytic skills to plan, 
implement, and evaluate health policy; and to 
produce research evidence to support policy 
development and change. Graduates are ready 
to assume policy analysis and advocacy roles in 
healthcare provider organizations, integrated health 
care delivery systems, government offices, academic 
institutions, health services research firms and 
community-based or advocacy organizations. 
What differentiates this program from others of 
its kind is its emphasis on problem identification, 
modeling and policy solutions; its system approach; 
its treatment of health care as a business; and its 
access to a broad, nationwide network of health 
policy experts and practitioners who can work  
with students on a vast array of meaningful  
policy projects.
The MS-HP degree program and its Certificate 
option are open to practicing medical and 
healthcare professionals of all stripes; to healthcare 
administrators working in healthcare plans, 
management companies, and government agencies; 
to academics and HIT professionals and analysts; 
to recent college graduates with degrees in public 
policy, economics, political science or a healthcare 
field; and to students currently enrolled in a 
medical, nursing, law or pharmacy program who 
wish to earn an additional degree in health policy. 
JSPH’s Master of Science in Healthcare Quality 
and Safety (MS-HQS) represents a ground-
breaking contribution to healthcare education. 
As the second program of its kind in the nation, 
the degree prepares healthcare professionals—
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providers, payers, purchasers, and policymakers 
—to be leaders and advocates in the design, 
implementation and dissemination of programs 
and policies that measurably improve healthcare 
quality and patient safety. The strength of the  
MS-HQS is its focus on organizational behavior and 
change and the advanced use of quality and safety 
tools and methods. Graduates serve as chief quality 
or safety officers, quality analysts, and program 
leaders for quality improvement in all venues of 
healthcare delivery. 
The MS-HQS and the Certificate in Healthcare 
Quality and Safety are intended for physicians, 
nurses, pharmacists, and other healthcare 
professionals working in the full range of 
healthcare settings; for individuals working 
in payer settings, including managed care and 
other insurer positions, who have background 
or interest in quality and utilization, disease or 
case management; for risk managers, healthcare 
program administrators, and HIT specialists; 
and for individuals working in public health, 
government or regulatory positions at the local, 
state or federal level. The programs are also well 
suited to students currently enrolled in a medical, 
nursing, law or pharmacy program who wish to 
earn an additional degree in healthcare quality  
and safety. 
JSPH’s Master of Public Health (MPH) is a strong 
generalist program that stresses competencies in 
five public health areas—behavioral and social 
sciences, biostatistics, environmental health 
sciences, epidemiology, and public health policy 
and management. It prepares professionals to work 
in multiple venues within public health— state 
and local public health departments and health 
centers, non-governmental health organizations 
(NGOs), schools and universities, professional 
health agencies, health insurance companies, and 
businesses such as the pharmaceutical industry. 
Graduates track disease outbreaks, conduct 
community health assessments, plan public 
 health education programs, and develop public 
health policies. They also engage in public  
health research and work internationally in  
global health environments. 
The MPH program is designed for both recent 
college graduates and working professionals.  
The Certificate in Public Health is an excellent 
option for practicing health professionals working 
in government, community health organizations, 
health insurance companies, the pharmaceutical 
industry, and academic institutions who wish to 
deepen their experience with public health practice. 
To encourage participation of medical, law and 
nursing students, JSPH also offers joint degree 
programs—MD/MPH, JD/MPH, MJ/MPH and 
MSN/MPH— in which all coursework can  
be completed in 12 months.   
Caroline Golab, PhD
Associate Dean for Student and  
   Academic Affairs 
Jefferson School of Population Health
David B. Nash, MD, MBA 
Dean, Jefferson School of Population Health
For more information about the School’s  
programs or to apply to one of them, contact JSPH 
at 215-503-5305 or visit us at www.jefferson.edu/
population_health/. Together, we can make a 
world of difference in U.S. healthcare—and 
Jefferson can lead the way.   
1st Annual IHI Open School Chapter Congress
Doctors, nurses, pharmacists, health 
administrators, and public health professionals 
enter the healing professions to make a difference 
in the lives of their patients and populations. 
The Institute for Healthcare Improvement (IHI) 
established the IHI Open School for Health 
Professions in September 2008 to create an  
outlet for students in these disciplines to  
engage in conversations about the quality and 
safety of our healthcare systems. 
IHI established the Open School  because quality 
and safety are not typically offered as part of the 
curriculum, even as electives. Built on the “aims 
for improvement” set forth in Crossing the Quality 
Chasm, A New Health System for the 21st Century,1 
the IHI seeks to engage students in quality and 
safety while they are in training. Despite the 
notable and highly publicized efforts of  the IHI  
to improve the quality of healthcare2, 3, that work 
will only be sustainable if the healthcare leaders of 
tomorrow are sufficiently prepared and ready  
to take appropriate action.
On January 10, 2009 representatives from the IHI 
Open School Chapters converged on Cambridge, 
MA for the first Chapter Congress. For many, 
this was the first opportunity to meet face to 
face and build a network of contacts. Donald 
Berwick, MD, MPP, FRCP, President and CEO of 
the Institute for Healthcare Improvement, and 
Lucian Leape, MD, Adjunct Professor of Health 
Policy at Harvard School of Public Health, were 
in attendance and commented on the importance 
of student involvement in quality and patient 
safety. Presentations and exercises demonstrated 
the importance of teamwork and communication 
among an interdisciplinary group of healthcare 
professionals. Brainstorming sessions were held 
throughout the day. The IHI Open School is 
growing rapidly, reflecting the organization’s  
and the students’ commitment to building  
their chapters.  
Valerie P. Pracilio
Project Manager for Quality Improvement  
Jefferson School of Population Health 
For more information about the IHI  
Open School and the Thomas Jefferson  
University Chapter, contact the author at:  
Valerie.Pracilio@jefferson.edu. 
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In the tradition of Asclepius, Greek god of 
medicine, it is difficult to envision a time where 
physician healers would turn to management 
science to hone their skills. Yet that is exactly 
where we stand today. With increasing scrutiny  
of the medical profession—targeting cost, access 
and quality of care—a growing number of 
physicians are seeking formal business training 
to adapt to the evolving healthcare industry.1 
Recognizing the value of a complementary 
business education, especially for training 
physician leaders, medical and business schools 
across the country have been forging partnerships 
to address this knowledge gap through the 
concurrent pursuit of the MD and MBA degrees.
First established in 1970 at the University of 
Pennsylvania, MD/MBA dual-degree programs 
have seen rapid growth in recent years. Climbing 
in number from 6 established programs in 
1993 to the 50 that are currently recognized by 
the Association of American Medical Colleges, 
educational leaders are recognizing the demand 
for a modified educational structure.2  At the 
time of a 2003 study, nationwide enrollment  
for MD/MBA programs reached 329, and will 
likely continue to rise as awareness increases  
and more programs are established.3 Yet with 
such a new phenomenon, questions inevitably 
arise as to the career paths these students will 
pursue,  the motives inspiring their unorthodox 
education, and the impact that it will have on 
medicine and the delivery of healthcare.
Of specific concern is the identity these students 
will develop as they are schooled in seemingly 
dichotomous theoretical foundations. While 
studies have shown that the majority of MD/
MBA students intend to continue along the 
traditional path of medical education into 
residency, complementing their clinical practice 
with administrative duties, opportunities in the 
healthcare industry  are luring some students to 
postpone or forego residency training to pursue 
career paths such as management consulting.4  
This small but important trend creates two 
different endpoints of the dual-degree product: 
the clinician with a basic education in business 
management as opposed to the executive with 
formal medical knowledge and credentials. 
Though the market has shown the value and  
need for both career pathways, how these students 
will ultimately utilize their training may have 
great implications for both the future of medical 
education and the healthcare industry as a whole. 
Noting that much could be learned by establishing 
a means to track these cohorts into the future, 
Jefferson Medical College has been working with 
leaders at institutions offering the dual-degree 
to establish a national registry of MD/MBA 
programs and their matriculants. Although in its 
infancy, this database is similar to the Jefferson 
Longitudinal Study of Medical Education, which 
has systematically followed the careers of all 
Jefferson Medical College graduates since 1968. 
The national registry of MD/MBA graduates 
will have the potential to serve as the basis for 
studies of these young physicians to describe their 
personal characteristics, track their professional 
development and study the programs from which 
they obtained their education. 
Unlike the practicing physician who returns  
to obtain an MBA after years of service, these 
dual-degree students are initiating their  
careers with an additional skill set. Novel in 
its theoretical implications, this growing trend 
deserves systematic observation to elucidate 
the impact of these individuals on the state 
of healthcare. Although they may be limited 
in number,  these students are positioning 
themselves to assume active roles in defining the 
future of the delivery and financing of healthcare, 
and thus the future of medical practice.  
Marc B. Royo
MD/MBA Candidate 2011 
Jefferson Medical College/ 
Widener University
J. Jon Veloski, MS 
Director, Medical Education Research 
Center for Research in Medical  
Education and Health Care 
Jefferson Medical College
For more information contact the authors  
at Marc.Royo@jefferson.edu and  
Jon.Veloski@jefferson.edu. 
Tracking the Future of Healthcare Leadership: The MD/MBA Student
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Stay Connected
Nash on Health Policy Blog
Share your thoughts and comments by visiting:  http:nashhealthpolicy.blogspot.com/
Jefferson School of Population Health Website 
See what’s new with JSPH by visiting:  www.jefferson.edu/population_health/
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The Obama Administration and leaders of the 
111th Congress have made health care reform a 
priority—specifically emphasizing prevention 
and population health as a way to improve 
Americans’ health and reduce costs over the  
long term. A key component is to address  
the growing need for appropriately trained  
health care providers working in our public  
health system. 
There are a number of health care challenges 
that require physicians who are trained to treat 
individual patients within a larger context of 
family, community and society. 1, 2 These include 
infectious diseases; the significant increase  
in chronic disease due to the aging of our 
population; the potential detrimental health 
impact of climate change; and the continued 
racial, ethnic, and cultural disparities in health 
care access in our increasingly diverse society.  
A recent report by the Bureau of Labor Statistics 
estimated that the U.S. needs 20,000 physicians  
in public health, with an annual replacement  
need of 1,350.3
The appeal to improve public health education 
for physicians is not new, but instead has grown 
steadily over the years. Since 2000, several reports 
have been issued by national organizations such 
as the Institute of Medicine on the need and 
strategies to improve population health education 
in medical curricula. 4, 5  The Association of 
American Medical Colleges (AAMC) has 
expressed continued interest in public health 
education for physicians and dedicated a recent 
issue of its journal, Academic Medicine, entirely 
to Population Health Education. 6  Together, 
these reports have called for medical students’ 
education to include epidemiology, biostatistics, 
disease prevention/health promotion, health care 
organization and management, environmental 
health, community-based participatory  
research and several other educational topics  
that are common to a masters degree in public 
health (MPH). 
In fall 2008 the AAMC, in cooperation with  
the Centers for Disease Control and Prevention 
(CDC), developed cooperative agreements with 
medical schools to develop Regional Medicine-
Public Health Education Centers (RMPHECs) 
with the goal of improving the integration 
of population health into medical education 
curricula. The development of an initial  
draft set of population health competencies  
for medical students is currently under review.7  
The competencies will be directly linked to  
long-standing public health competencies. 
Thomas Jefferson University (TJU) recognizes  
the need to incorporate population health 
principles and education within its medical 
educational program to help meet the growing 
workforce development needs. Medical students 
receive basic education on population and public 
health, and many conduct clerkships and/or 
volunteer their time in community-based health 
settings as part of their educational experience. 
TJU has provided a master’s level public  
health program since 2002 and in the current 
academic year, initiated a joint five-year MD/MPH 
degree. The joint MD/MPH program augments 
medical education focused on quality and 
effective clinical practice with evidenced-based 
public health and prevention principles,  
theories, skills, and practice. 
Medical students participating in this joint 
degree program will take a full year off from 
their medical education, typically after year two 
or year three, for an intensive year in Jefferson’s 
nationally-accredited MPH program.  During  
that year they complete coursework and a 
community-based clerkship experience, returning 
to medical school the following year. The MPH 
capstone research project is usually completed 
during the subsequent year of medical school. 
Medical students can receive up to 9 transfer 
credits for the 45-credit MPH program based  
on their Introduction to Clinical Medicine  
two-year course, which includes much population 
health-related instruction, and their selection  
of population health elective experiences.
The academic goal of the Jefferson  School of 
Population Health is to prepare leaders to  
develop,  implement, and evaluate health 
policies and systems that improve the health of 
populations. Graduates of the program will be 
well-prepared to serve as leaders in a variety 
of settings including government, insurance, 
professional organizations, academic institutions, 
community-based organizations, as well as 
clinical practice both in the U.S. and globally.    
Rob Simmons, DrPH, MPH, CHES 
Director, Master of Public Health Program 
Associate Professor  
Jefferson School of Population Health
For more information on Jefferson’s public  
health program, contact the author at  
Rob.Simmons@jefferson.edu.
Training Future Physicians as Public Health Leaders: 
Jefferson’s MD/MPH Graduate Education Program
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What is the primary mission of the 
Clinical Skills Center?
DB:  The Center’s goal is to produce enthusiastic, 
empathetic, caring, scientific-minded 
physicians who work with others to the 
benefit of their patients, colleagues and 
students. Using the 7 Principles of Simulation 
(Table 1) that we have developed, we’ve 
created what we believe is an optimal 
learning environment that will allow 
learners to efficiently and effectively learn 
the skills necessary to practice and teach 
medicine. We want them to think critically 
about the skill sets that we teach them, to 
ask questions on the evidence behind the 
physical examination skills that are taught. 
We think that teaching and evaluating in 
the Simulation Center will help to translate 
these skills to the bedside. Finally, we want 
to inspire our students to become teachers 
themselves and to serve as role models for 
future generations. We hope that, through 
its combination of curriculum and faculty, 
the Center can help our graduates model the 
ideal Oslerian physician: “Equal parts doctor, 
teacher and priest.”
How did you first start to become 
interested in this field?
DB:  We started in 1990 because we, and many of 
our teaching and academic colleagues, felt 
that the student and resident physicians  
had significant deficits in physical diagnosis 
and examination skills which are so 
important to the provision of high quality 
(and cost effective) health care. With several 
mentors at the Milwaukee VA and the 
Medical College of Wisconsin, we developed 
a unique elective course for senior medical 
students that allowed them to learn an 
advanced version of physical examination 
during their clinical years. This course served 
as a paradigm for all of our future teaching 
endeavors. The evidence-based curriculum 
used checklists to make certain that everyone 
received the same teaching. Patients with real 
findings were examined by the students in 
a reproducible standardized method. And, 
we developed an evaluation and assessment 
tool that was a primitive Objective Structured 
Clinical Exam (OSCE). Finally, we conducted 
research on this curriculum and, most 
importantly, translated it to the bedside. 
  Over 1000 students have participated in  
this course, which continues to be our para-
digm for all clinical skills teaching  
and is the backdrop to our development  
of the 7 Principles of Simulation in teaching 
and evaluation. The Standardized Patient 
(SP) program that began with that course 
evolved and expanded to be used in many 
other venues: in Boston, at Harvard Medical 
School; in Minneapolis, at the University of 
Minnesota; and then we brought it to Jeffer-
son when we were recruited here in 2001. 
 KB:   The Step 2 Clinical Skills of the Boards, 
an examination that graduate medical 
students need to pass in order to receive 
a license to practice medicine, affirmed 
the need for simulation teaching and 
assessment in a standardized way. This 
led to using simulation to teach skills in 
physical examination, history-taking, and 
communication skills. There has been a kind 
of renaissance in physical examination skills 
and, as it evolved, we began incorporating 
other types of simulation (i.e. manikins)  
into the curriculum. Today’s manikins are 
much more sophisticated and durable, and 
the sound quality has markedly improved  
in the last few years. 
When you were students did you have 
exposure to this?
KB:   No, none. The reason I got involved in physi-
cal exam was because I felt the training I had 
did not give me enough to be able to do what 
I need to as a physician. It was a deficiency in 
education that motivated us to do this.
DB:   The things we teach in the Simulation 
Center— the cases we present and the 
checklists we have written—are items 
that we wish that we had seen, learned 
and experienced in our medical training. 
We never had a chance to practice with 
standardized patients, we never had a  
chance to hear classic murmurs in a 
minimal-stress environment. 
  We practiced medicine for a while in rural 
Nepal, where there was no electricity, no 
imaging, no lab tests. There you must depend 
on the fundamentals of clinical skills-history 
and physical examination to diagnose and 
follow patients. We had to put in practice what 
we had been teaching. To practice medicine 
with no modern ancillary tools was a challenge, 
but a delicious challenge. 
  If, God forbid, you are somewhere without 
electricity and thus without radiographs, you 
can still assess the patient in a professional 
and scientific fashion with the skills of exam 
and history. That is being a physician—
using your senses and your knowledge to 
determine a clinical diagnosis. 
KB:   Health care delivery has changed. Hospitals 
stays are shorter, and more is done in 
outpatient visits. When I was a student,  
I could observe the natural history of the 
acute or sub-acute disorder of a patient 
 over the course of their entire stay of  
1, 2, or even 3 weeks. In a relatively non-
structured fashion, I could examine these 
patients and learn and practice clinical skills 
there. By simulatingthe hospital environment 
in a standardized fashion, we allow the 
student to learn clinical skills and provide 
opportunity for structured practice. The SP 
allows the students to learn and practice the 
skills in safe, structured environment. The 
Center does not, however, supplant bedside 
teaching. We allow the students to practice 
invasive procedures on plastic models first, 
instead of working on a live patient. 
DB:   We can state that the students know how 
to perform the steps in the skills and even 
how to effectively interpret and document 
these skills. Because it is a simulated 
environment, we cannot state that they are 
clinically competent; that will always require 
observation and assessment at the bedside. 
We need to be able to translate what we do to 
the bedside. Clearly, simulation centers allow 
for the effective introduction to the teaching 
The University Clinical Skills and Simulation Center: A Jefferson Gem
Part I Interview with Dale Berg, MD and Katherine Berg, MD  
Co-Directors of the University Clinical Skills and Simulation Center (UCSSC) 
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of skill sets, as well as the experience of 
structured practice. Their power is to more 
effectively prepare the student with the tools 
to learn better, under the tutelage of faculty, 
at the bedside. Simulation cannot replace 
bedside teaching or assessment. It makes it 
more efficient, more standardized, and more 
reproducible across learner groups. 
KB:   We have been in other institutions with 
manikins and other sophisticated equipment 
that sits unused in the corner. Without 
faculty who are trained to use it, it is really 
not valuable. One of the challenges we face 
nationally is that everyone gets money to put 
up the centers, but the operational costs of 
faculty are not factored in. At Jefferson we 
have a very dedicated faculty to support the 
learning environment.
DB:    Jefferson is the first place that we have 
worked as teachers where the mission of 
education is not the weak sibling relative to 
other center missions. The model here has 
been to build the classrooms and teaching 
venues and to fill them with quality and 
innovative teachers and faculty leaders in 
simulation. Jefferson has built a sustainable 
model for the present and the future, and  
we are proud to be a part of it.
KB:   We have incorporated simulation into 
all levels of the curriculum throughout 
medical school. During the first and  
second years we have simulation sessions  
on a regular basis to teach them the skills  
of history taking and recording and  
physical examination. 
  The history and physical examination 
is embedded into and in parallel with 
their classroom work. When they learn 
cardiovascular diseases in classroom, 
they do skills sessions using Harvey®, the 
cardiopulmonary patient simulator, and  
SPs who are trained for cardiac physical 
exam and history. What they learn in class  
is translated into actions in the skills that  
are learned at the Center.    
 For more information on the University Skills 
and Simulation Center contact the authors at  
dale.berg@jefferson.edu and katherine.berg@
jefferson.edu.
Part II of this intervew will appear in the June 2009 
issue of the Health Policy Newsletter.
The 7 Principles in Simulation Teaching and Simulation Centers
1   Simulation programs must be developed in a context that is useful to the learner. The programs should be based upon 
real cases that are contextually appropriate to the level of training.  
The leaders of a simulation center must know the overall medical 
school curriculum in order to create reproducible simulation 
teaching modules. Simulation teaching and evaluation is built  
into the curriculum in a longitudinal basis, starting from week 
one and going on through each year of undergraduate education.  
Graduate education and faculty development are increasingly 
becoming involved.
2    Simulation programs need to have a robust Standardized Actor/Patient (SP) program.  One of the pivotal components 
of a Center is a robust and active SP program. Standardized 
patients are actors paid to provide a history, feign certain 
physical examination findings, provide feedback, and evaluate—
using a checklist—the skills of students. They are of great use 
in evaluation and skills assessment, but perhaps are best used in 
structured practice and skills attainment. They are also used as 
standardized residents, attending, and family members so that 
teaching and evaluation programs can be diverse. 
3   The experiences must be standardized. All students at a certain level of training need to have a reproducible, standardized 
paradigm to learn the same skill set. This allows for a fairer and 
more competency-driven assessment of the learner’s skill set.  
The faculty leaders of a center must be able to develop checklists 
that are appropriate and credible to the skills set. 
4  The simulation experience must be credible. The learner must be able to suspend disbelief during the encounter so that 
the educational and assessment value is optimized.  This requires 
context, as described above, but also requires some “magic” and 
“stagecraft” and innovation. The SP must be trained and directed 
in acting the case in a specific and appropriate manner. In 
addition, appropriate tubes, furniture, smells and even simulated 
fluids should be in the room as needed to optimize credibility.  
The plastic and electromechanical simulators need to be vetted 
and used by teachers who perform the procedures on real 
patients. Finally, the faculty leaders need to be able to combine  
the standardized patient simulation with the plastic models.  
This hybrid or chimera approach is the next level of simulation.  
5    There must be a method for effective debriefing after the encounter. Debriefing is one of the most powerful tools we 
have to teach in the simulation environment. A faculty may 
watch the encounter in one of 3 ways: direct observation  
from behind a one-way mirror, or watch a live video-feed  
watch the encounter on a previously recorded video disc.  
The faculty can work with the learner/s to learn from and  
build upon what was performed correctly and remediate  
what was performed incorrectly. 
6    The simulation curricula must itself be critically evaluated and researched. A fundamental aspect of simulation in 
medical education is that it must be studied in a prospective  
and scientific manner. Simulation is an expensive innovation  
and in order for it to positively evolve, we must be able to  
study it and ascertain what does and does not work. 
7    Simulation must be translated to the bedside. This is the overarching and most fundamental of principles. Simulation 
may make teaching more efficient, but it will never supplant the 
need to learn from the patient under the direct mentoring of 
an accomplished teacher. Faculty from the center must be able 
go from simulation to the bedside. Bedside rounds must be a 
component of any simulation curriculum. 
 Developed by Dale Berg, MD and Katherine Berg, MD. 
Change Your Life.  
Change Health Care.
Make a world of difference – 
the Jefferson way
Jefferson School of Population Health
• Master of Public Health (MPH)
• Master of Science in Health Policy (MS-HP)
•  Master of Science in Healthcare Quality  
and Safety (MS-HQS)
Full-time options
Part-time options for working professionals
Easily accessible Center City location
Redefining Healthcare Education 215-503-5305
Thomas Jefferson University www.Jefferson.edu/population_health/
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While some adults enjoy a seamless transition 
through the age continuum, others experience 
increased isolation and physical and cognitive 
impairment as they age.1  This isolation is 
typically the result of physical limitations that 
inhibit socialization, a lack of access to social 
networks due to retirement and relocation, or 
death of friends and family. Often, these factors 
hamper the ability of older adults to maintain 
their homes, despite their overwhelming desire 
to remain in them.2 At the same time, adults are 
living longer in the U.S.,3  making supportive, 
affordable housing for older Americans an 
increasingly pressing societal issue.
Naturally Occurring Retirement Community 
(NORC) programs, which first emerged in the 
mid-1980s,1 represent a growing, grassroots 
trend in community-based supportive housing 
services for older adults. NORC is a demographic 
term that encompasses zip codes, neighborhoods, 
or regions that contain a large number of older 
adults who have “aged in place,” meaning they 
have continued to live in their own homes as they  
have aged. Nationally, more than 80 NORC 
supportive-service programs receive public  
funding, and a host of others are sustained 
privately.4 The goal of NORC programs is to allow 
residents to remain in their homes by providing a 
“safety net” consisting of a range of psychosocial, 
health care, and other support services. 
In 2001, the Administration on Aging contributed 
to the expansion of this trend by appropriating 
over $3 million in grants for five NORC 
demonstration projects around the country.1  
These projects aided in the development of 
effective NORC models of service, and also 
confirmed the efficacy of neighborhood-based 
supportive services, which tend to be proactive 
rather than reactive.1, 5 
This article highlights Philadelphia’s West Oak 
Lane (lower Northwest Philadelphia) NORC 
Initiative. Founded in 2007, this is a program of 
the Albert Einstein Healthcare Network (AEHN) 
and the Strategic Alliance for the Elderly (SAFE). 
SAFE, founded in 2004, is a coalition of local 
organizations that strives to strengthen the 
community’s capacity to meet the needs of older 
adults by sharing knowledge, pooling resources, 
and pursuing collaborative opportunities. 
AEHN provides medical care, while SAFE  
assists in collaborative problem-solving and 
resource-sharing. Staffing for NORC includes a 
full-time project director, part-time outreach 
worker, and part-time Master’s-level social work 
student. Program services are provided via  
phone, at the NORC office, or in clients’ homes. 
The program also benefits from an active 
Consumer Advisory Board, comprised primarily 
of area residents over 60, many of whom care  
for their own aging parents. 
Residents are encouraged to access the program’s 
services primarily through referrals, whether from 
government and aging programs, SAFE member 
agencies, spiritual organizations, or word-of-
mouth from other NORC clients. The program 
distributes a quarterly newsletter and has its  
own website (www.einstein.edu/norc). It also  
has an active community outreach agenda and  
a dynamic volunteer corps.   
While the West Oak Lane NORC is thriving, there 
are a number of hurdles that impede its full 
efficacy. The program is still in its trust-building 
stage, which can make it difficult to engage 
neighborhood residents around their medical or 
mental health needs. The staff members work to 
overcome this challenge through regular outreach 
efforts and extensive community involvement. 
Budget constraints also affect the program’s 
impact, though it is actively pursuing funding 
opportunities to facilitate expansion and ensure 
its longevity. Finally, the program is not able to 
address all of residents’ needs; when possible, 
referrals are made to other agencies. For example, 
West Oak Lane residents often fall just above 
income limits for certain assistance programs 
(including Medicaid, Medicare prescription 
assistance, etc.). This means that needed services 
that require out-of-pocket payment, such as  
home maintenance and repair and property  
taxes, often go unmet.
The range of services continues to evolve.  
The initiative has implemented both a friendly-
visitor program (for socialization and errands) 
and a general home-visiting program (for 
more acute, targeted needs). Home-repair and 
computer-access programs are in development; 
the latter is aimed at increasing the availability  
of information and socialization opportunities  
for homebound older adults.
The pending launch of a computerized database 
will facilitate more expansive assessments to help 
evaluate the program’s efficacy. Included will be 
an assessment of the NORC’s success in linking 
residents to community resources that enable 
them to remain at home, and its ability to bridge 
gaps in existing service.
Ideally, the development of similar programs  
in other communities will facilitate the creation 
of a supportive aging network for older adults. 
Helping elders age in place makes sense in 
important ways. Allowing longtime homeowners 
to remain in their communities helps to keep 
housing values) stable. NORCs also afford  
elders an alternative to long-term care options, 
which are not only financially prohibitive for the 
average senior, but often provide “overcare”  
or “undercare.”4  
Sara R. Popkin, MSW, LSW 
Project Director, West Oak Lane NORC 
Albert Einstein Healthcare Network
For more information contact the author at:  
popkins@einstein.edu. 
The West Oak Lane NORC Initiative: An Innovative  
Aging-Support Program
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The 6th Annual Interclerskhip Day on Improving 
Patient Safety was a unique opportunity for 
Jefferson Medical College’s (JMC) 3rd year students 
to explore their own attitudes and beliefs about 
medical error, disclosure, and patient safety,  
while benefiting from lessons learned from the 
aviation model of crew resource management  
and its application to medicine. Sponsored by 
Office of the Dean of JMC and the Jefferson  
School of Population Health (JSPH), the  
program was moderated by David B. Nash, MD, 
MBA, the founding Dean of JSHP. The day opened 
with a welcome from Michael J. Vergare, MD,  
Senior Vice President of Academic Affairs for 
Thomas Jefferson University. 
The keynote speaker was internationally known 
aviation safety expert, John J. Nance, JD. Nance 
is the founding board member of the National 
Patient Safety Foundation; a former airline pilot; 
and a broadcast analyst on aviation for ABC News. 
He presented compelling evidence illustrating 
how medicine can use techniques from the 
airline industry to improve patient safety and 
increase professionalism. He emphasized the 
importance of communication and the creation of 
an environment and culture that allows a junior 
team member to actively participate and speak up 
if something is amiss. This type of environment 
fosters teamwork while ultimately improving 
patient safety. 
Improving patient safety must include an 
understanding of one’s errors. David W. Andrews, 
MD, FACS, Director of Neuro-Oncologic 
Neurosurgery and Stereotactic Radiology shared, 
with great honesty and humility, his own story 
of a medical error. This helped the audience to 
process the reality of what might actually lead  
to a medical error and how everyone is affected  
by it. Daniel F. Ryan, Esq. then discussed the  
legal implications of medical error, including 
disclosure and apology. 
Following the morning presentations, students 
had the opportunity to meet Mark L. Tykocinski, 
MD, the new Dean of Jefferson Medical College, 
as he discussed his background and role during 
a luncheon presentation. Dr. Tykocinski was 
formerly the Simon Flexner Professor and Chair 
of the Department of Pathology and Laboratory 
Medicine at the University of Pennsylvania. As 
Dean of JMC he is responsible for the educational, 
research, and clinical missions of the college. 
The afternoon program began with an award 
presentation to Jay Scott, Executive Director 
of Alex’s Lemonade Stand Foundation. The 
inaugural Patient Advocacy Recognition Award 
honored the Foundation for their outstanding 
regional and national work advocating for the 
rights of patients and their families. Following 
the ceremony, Mr. Scott shared a poignant story 
about the initial time period when his daughter 
Alex first developed symptoms of her disease and 
the frustrations he encountered early on when 
trying to get a diagnosis, appropriate care, and 
effective treatment. It was a moving and emotional 
story which revealed the shortcomings of the 
medical system and highlighted  opportunities for 
improvement. Mr. Scott’s take-home message for 
the students was to listen. 
The next presentation focused on recognizing 
barriers to physician disclosure. Joseph Spiegel, 
MD, Associate Director of Otolaryngology at 
Jefferson, explained how fears—particularly  
fears of lawsuits—can serve to hinder  
disclosure and trust. Guilt and shame, patient-
provider perceptions and expectations also 
impede disclosure. Dr. Spiegel suggests that 
increasing confidence in the law and reforms to 
policies are some of the steps that will help to  
encourage disclosure. 
It can be very difficult to communicate a bad 
outcome to patients and families. Jason Baxter, 
MD, MSCP, Assistant Professor in the Division of 
Maternal-Fetal Medicine, offered a very interactive 
presentation and dynamic exchange with the 
audience that helped to characterize the elements 
of a successful encounter with patients and 
families. Through the use of case scenarios and 
student involvement in role-plays, the audience 
observed important skills, actions, language, and 
non-verbal cues which enhance the provider-
patient encounter and lead to patient satisfaction.  
This particular clerkship program provides  
an important venue for integrating patient  
safety issues into educational programming for 
JMC students and it will continue to thrive in 
future years to come.   
6th Annual Interclerkship Day: Improving Patient Safety 
January 5, 2009
Upcoming Public Health Events
making a World of difference:  
Jefferson’s Public health initiatives 
Symposium and Luncheon 
Wednesday, April 8, 2009  
11:30 am – 1:00 pm     
Jefferson Alumni Hall Atrium
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Social media has become pervasive in today’s 
society. Blogs, forums, social networks, and virtual 
worlds are easily accessed and attract many 
users. Consumer health information has become 
increasingly prevalent in a variety of media 
formats, and has become especially significant in 
social media. How health information delivered 
through social media affects prevention, behavior 
change, decision-making, knowledge, and health 
perceptions is the fundamental question in the 
quest to reach consumers. 
Cheryl Heiks is Director of Communications and 
Events of LLuminari Inc, an innovative health 
communications company located in Wilmington, 
Delaware. LLuminari is the parent company 
for BeWell.com, the first expert-guided social 
network on health. LLuminari Inc. was founded 
by the internationally renowned experts, Dr. 
Nancy Snyderman, Dr. Susan Love, and Elizabeth 
Browning. This dream team of over thirty of 
America’s leading health and wellness experts 
was launched in O, The Oprah Magazine with 
a 12-month editorial series. Their vision is to 
give consumers easier access to health experts 
with reliable information. The company focuses 
on women’s health issues, but also includes 
pediatrics, family health, and recently, men’s 
health. From the beginning, the company was 
grounded in its commitment to multicultural 
health. LLuminari focuses on consulting work; 
live and on-line events; content; products for 
consumers; and landmark research studies. 
LLuminari launched BeWell.com in December 
2008. The site is designed to offer networks of 
communities focused on specific health care 
topics, with access to a panel of medical experts.  
It also offers resources, such as articles, blogs, 
online tools and videos. What makes BeWell 
special is its ability to offer current cutting-edge, 
transparent information through postings, and 
conversations with leading experts. BeWell 
users appear to be very interested in the topics 
such as infertility, breast cancer, care giving, 
smoking cessation and heart disease. BeWell.
com is a fascinating hybrid example of how social 
networking can blend with consumer health 
information (factual and evidence-based)—
guided by medical experts. Though conversations 
between users can be fluid, users cannot get lost  
in a maze of inaccurate information. 
Cheryl Heiks discussed the future of social media 
which she feels will emphasize the mobile device 
as the primary connection tool to the internet. 
She also described the continuum of blurred lines 
between business and social media which can be 
both complex and beneficial at the same time.   
BeWell.com – The Value of Social Media in Health Communication  
Cheryl Heiks, 
Director of Communications and Events 
LLuminari Inc. 
January 14, 2009 
Public Policy and Cardiovascular Disease: Making the Connection 
Timothy Gardner, MD 
President, American Heart Association  
Medical Director, The Center for Heart and Vascular Health, Christiana Care Health System 
February 11, 2009
Cardiovascular disease is the major cause of death, 
for both men and women, in the United States. 
The societal impact and burden of this disease 
is a major concern to clinicians, advocates, and 
policy experts. Timothy Gardner, President of the 
American Heart Association (AHA), provided an 
excellent overview of this issue at a recent Health 
Policy Forum. 
Dr. Gardner first described the role and history of 
the American Heart Association. From the grass 
roots level to the federal level, AHA is primarily 
an advocacy organization. Its mission is focused 
on building healthier lives, free of cardiovascular 
disease and stroke. More specifically, AHA’s impact 
goal is to reduce coronary heart disease, stroke, 
and risk by 25% by 2010. Its primary activities 
include support for research, public education, 
advocacy, and professional services. 
The American Heart Association conducts 
multiple programs and campaigns which often 
focus on increasing public awareness and 
encouraging behavior change. For example, Go 
Red for Women is a campaign aimed at supporting 
AHA’s goals by educating the public regarding 
the misperceptions of coronary disease while 
raising money for research. The Heart of Diabetes 
is a program that assists and supports those 
affected by Type II Diabetes in making healthy 
lifestyle behavior changes. The American Stroke 
Association (a division of AHA) uses another 
educational campaign, The Power to End Stroke, 
to provide outreach and education to African 
Americans on ways to reduce their risk of stroke. 
Dr. Gardner discussed the national crisis of 
childhood obesity and its implications on their 
risk for future cardiovascular disease and Type 
II Diabetes. The societal response to this crisis 
is critical in order to improve the overall health 
of the population. Dr. Gardner refers to this as 
“primordial” prevention, or keeping those who 
are healthiest and not yet at risk from acquiring 
those risk factors that can make them vulnerable 
to disease. 
Policies at the governmental level can play 
a particularly important role in prevention. 
For example, it was Surgeon General Koop, a 
champion of anti-smoking campaigns, who 
 laid the foundation for influencing awareness  
and behavior change nationally. This, in  
turn, had an effect on decreasing the rate of 
cardiovascular disease in the US. The AHA has 
 an Office of Federal Advocacy and it continues  
to work closely with the National Institutes  
of Health, the Centers for Disease Control and 
Prevention, and the Agency for Healthcare 
Research and Quality.  
For more information on the American  
Heart Association, visits its Web site at:  
www.americanheart.org.
Health Policy Forums
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For decades, the pharmaceutical industry was 
lauded for its role in improving the health of 
the world’s population. However, the industry 
has faced significant challenges in recent years. 
Its pipeline of new products has weakened, and 
costs for research and development, sales, and 
marketing have increased. Other issues—such as 
increased scrutiny of pharmaceutical practices, 
concern over the high cost of pharmaceuticals, 
and litigation related to several high-profile 
drug safety recalls—have served to tarnish 
the industry’s reputation. This combination of 
factors has forced the industry to reassess how 
it conducts business. This article will explore a 
few of the ways pharmaceutical companies are 
attempting to operate more efficiently and work  
to repair their image and regain public trust.
There has been considerable progress on the 
front to increase transparency regarding business 
practices. In March 2008, AstraZeneca announced 
that it would begin posting online a list of all 
contributions to state and federal political 
candidates, complete with recipients’ names and 
the total amount contributed.1 Two months later, 
Eli Lilly issued a statement in support of the 
Physicians Payments Sunshine Act, legislation 
sponsored by Senators Charles Grassley (R-Iowa) 
and Herbert Kohl (D-Wisconsin) to create a 
national registry of all payments over $500 made 
to physicians by pharmaceutical companies, 
medical device, and medical supply companies. 
Lilly announced it would begin voluntarily 
reporting this information online in 2009.2 
Merck,  in September 2008, pledged to disclose 
physician payments for speaking engagements 
beginning in 2009.3
Pfizer also made significant strides to reduce 
potential conflicts of interest. In July 2008 it 
announced that the company would no longer 
directly support Continuing Medical Education 
(CME) courses offered by for-profit medical 
education and communication companies.4 
This action attempts to ensure that CME  
courses remain focused on improving clinical  
care and patient outcomes, and are not mistaken 
for promotional programs.
Given the current difficult economic environment, 
many firms are turning to mergers and layoffs 
to improve efficiency and lower operating costs. 
High-profile mergers, such as the Eli Lilly and 
ImClone merger completed in November 2008,5 
can serve to expand a company’s pipeline of future 
medications and help to re-focus their efforts 
on innovative therapies instead of relying on 
“me-too” and patent-extending reformulations 
of existing medications. Wyeth, Merck and 
several other companies have, in recent months, 
announced workforce reductions of greater than 
ten percent.6 This reduction in the workforce 
poses many questions for the future, and it is too 
early to tell if it will also impact the progress of 
research and development.
A recent survey of industry stakeholders found 
that an astounding 94% of respondents believe 
that pharmaceutical companies spend too  
much on advertising.7 Reversing this belief is 
imperative to improving the current public 
perception of the industry. The industry is 
attempting to shed this image by regulating 
itself through guidelines set forth by the 
Pharmaceutical Research and Manufacturers of 
America (PhRMA). The most recent voluntary 
guidelines on direct-to-consumer (DTC) 
advertising, issued in December 2008, call for an 
end to off-label promotion in DTC advertising, 
and ask manufacturers to define risks as clearly  
as they define benefits in commercials and  
print ads.8 While these guidelines do nothing to 
address the sheer volume of advertising aimed  
at consumers, and are merely voluntary, they  
do address some key concerns that have been 
voiced by critics.
The changes occurring in the pharmaceutical 
industry certainly show an attempt to repair an 
image that has been tarnished in recent years 
by safety recalls, criminal fines, and compliance 
failures. The industry will need to continue to 
transform itself and focus on its core mission; to 
develop novel, innovative products that improve 
the lives of patients around the world  
Joe Couto, PharmD, MBA
Pharmacoeconomics and Outcomes  
   Research Fellow 
Jefferson School of Population Health 
For more information contact the author at:  
joseph.couto@jefferson.edu. 
The Evolving Pharmaceutical Industry
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Increasing Organ Donation Consent Rates in an Inner City Hospital
According to the United Network for Organ 
Sharing (UNOS), over 100,000 people in the US 
are waiting for an organ transplant.1 Eighteen 
people die each day, waiting. In April 2003, the 
Department of Health Resource and Service 
Administration (HRSA), set forth a national 
objective to abolish the waiting list for organ 
recipients: No person shall die waiting for an 
organ transplantation. HRSA established the 
Organ Donation Breakthrough Collaborative,2 
partnering hospitals that are leaders in organ 
donation with those that have a large donation 
potential and low donor yield. The goal: 100% 
referral rate (all eligible referrals are made)  
and a 75% conversion rate (the number of  
actual donations from eligible referrals). 
Albert Einstein Medical Center (AEMC) was 
identified by the Collaborative as one of the 200 
largest hospitals nationwide with the greatest 
potential for improvement. In March 2004, the 
conversion rate was a dismal 17% (1 donation of 
6 eligible referrals). While referrals of potential 
donors were made 78% of the time, only 30%  
were done in a timely manner. This meant we 
were not contacting our organ procurement 
organization (OPO) in time for a proper on-site 
evaluation. Our process was broken. 
In an effort to achieve the new national 
benchmark, AEMC partnered with Gift of Life 
(GOL), our local organ procurement organization. 
A core group from AEMC participated in the 
Second National Breakthrough Collaborative in 
San Diego, CA along with GOL staff. Likewise, 
a larger committee was created at AEMC to 
implement these shared best practices  
throughout our institution.3  
The Collaborative recommended we first identify 
barriers to AEMC’s donation process. Education, 
religious conviction, cultural sensitivity, racial 
relations, socio-economic status and community 
trust of the healthcare system were identified as 
key barriers impeding our objective.4 To improve 
our process and break through these barriers, we 
used the PDSA model—plan, do, study, act—a 
rapid-cycle quality improvement tool we learned 
at the Collaborative. 
Our first PDSA intervention resulted in the 
creation of the “trigger card” for all ICU staff. 
A 5x7 laminated card detailed how to identify 
all potential donors using clinical criteria, 
with emphasis on early identification. Our 
next intervention has become one of our most 
successful. Initially, GOL teamed with physician 
leaders, nurses, residents, clergy, interpreters and 
administrators exclusively from AEMC to educate 
and create “champions” for organ donation.5 
In one 8-hour off-site training session, these 
champions were instructed in an abridged format 
using practices learned at HRSA’s collaborative. 
Due to the success of this intervention at AEMC, 
GOL has expanded the champion training to over 
15 regional hospitals. 
Our most successful intervention to date is 
AEMC’s “trust bridge,” a mechanism involving 
the individual or individuals who have worked 
with the family of a patient who is moving toward 
becoming a potential donor, and has established 
a relationship of mutual trust and understanding. 
The team works closely with the family to safely 
and consciously transfer or share this trust with 
the organ donation coordinator.6 
According to Yuen, Burton, Chiraseveenuprapund, 
et al., there is an overall distrust of the medical 
profession.7 Specifically at AEMC, our clients are 
skeptical of medical practices involving donation 
and transplantation, believing that their organs 
will be used to save the lives of the wealthy and 
privileged. Consequently, we had to find a way to 
establish trust with patients and their families. 
Through an intense internal assessment, it 
was determined that our population feels best 
supported by the bedside nurse and AEMC’s 
pastoral support staff. For that reason, we chose to 
partner clergy and the primary nurse to support 
the donor family throughout the decision process. 
Also, due to our diverse population, we decided 
to involve interpreter services into the donation 
discussion when warranted. As a result families, 
through the support and trust of clergy, nurses, 
physicians and OPO coordinators, are consenting 
to donate more often. 
In conclusion, AEMC’s referral rate has increased 
to 100%, which has been sustained for over 4 
years. Our conversion rate, while not meeting our 
goal of 75%, has risen to 57% (an increase of over 
235%). The number of annual referrals has risen 
from 44 in 2003, to 116 in 2008. We continue to 
work diligently in our community to gain trust in 
our institution by dispelling myths and educating 
our patients through outreach. We will continue 
new interventions designed to increase the yield 
of organs per donation so that, someday, the 
waiting list will exist no more.  
George Alburger, MSN, RN
Nurse Manager SICU/Coordinator Organ 
   Donation Collaborative 
Albert Einstein Medical Center
Patrick Molloy, BSN, RN
Staff Nurse SICU/Organ Donation  
   Nurse Champion 
Albert Einstein Medical Center
For more information contact the authors at:  
alburgerg@einstein.edu and mollyp@einstein.edu.
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Defining the Active Ingredients of Rehabilitation
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Rehabilitation treatments and services are an 
important part of the healthcare system, and 
the need for such services is increasing. A larger 
proportion of the population is aging or elderly 
and, thanks to advances in medical technology, a 
number of individuals with disability who might 
previously have died are enjoying improved 
survival rates.1 Rehabilitation treatments are 
important both economically and in terms of 
quality of life, and can be expected to become 
more critical in the future.1 
Despite their importance, evidence supporting the 
efficacy and effectiveness of most rehabilitation 
treatments is sparse. There are many reasons 
for this, including inadequate funding of 
rehabilitation research, insufficient numbers of 
rigorously trained investigators, and the inherent 
complexity of the biopsychosocial (as compared to 
the biomedical) model that underlies the practice 
of rehabilitation.2 However, an increasingly 
recognized obstacle to research is the difficulty 
in defining many rehabilitation treatments with 
respect to their “active ingredients” in such a 
way that their impact can be studied. Similar 
to psychotherapy—whose efficacy has also 
been challenging to study—most rehabilitation 
treatments are delivered through some form of 
interpersonal interaction between rehabilitation 
therapist and patient/client, may be tailored 
to the goals, strengths, and weaknesses of the 
individual, and may incorporate multiple active 
ingredients.3 For example, consider several 
patients with difficulty walking after a stroke. 
All may be receiving “gait training”, but in one 
case the emphasis may be more on correcting 
impaired balance; in another on clearing the 
toe with each step; and another on being more 
attentive to obstacles in the environment while 
walking. Are these all the same treatment or is 
each patient receiving a different treatment? 
Because of these complexities, many attempts 
at clinical rehabilitation research have resorted 
to defining the treatments merely as numbers 
of hours of physical, occupational, speech, and 
other therapies; length of stay in a particular type 
of institution; or the goal of the treatment (e.g., 
“attention training”), as though the actual services 
delivered by clinicians and institutions during 
the treatment time are unimportant. Although 
numbers of sessions or hours may certainly 
be relevant, just as the dose of a medication is 
important, the dose does nothing to define the 
active ingredients of the treatment.
Recently the National Institute on Disability 
and Rehabilitation Research (NIDRR), a major 
funding source for rehabilitation research, 
awarded a 5-year grant to Marcel Dijkers, PhD 
at Mount Sinai School of Medicine for a project 
entitled, “Classification and Measurement of 
Medical Rehabilitation Interventions.” This 
project is intended to begin a process of building 
a taxonomy of rehabilitation treatments that 
is suitable for research purposes and may also 
facilitate interdisciplinary communication, clinical 
education, documentation, and billing. The grant 
includes a subcontract to Moss Rehabilitation 
Research Institute (MRRI) at the Albert Einstein 
Healthcare Network, an affiliate of Thomas 
Jefferson University, with John Whyte, MD, PhD 
and Tessa Hart, PhD as lead investigators at MRRI.
A taxonomy is a way of dividing a set of entities—
in this case rehabilitation treatments—into a 
set of ordered groups or categories. Building a 
taxonomy of rehabilitation treatments that is 
applicable across disabilities, treatment settings, 
and patient populations is an enormous task 
that cannot be completed in a single grant 
cycle. The current project contains several key 
activities that are expected to support ongoing 
taxonomy development beyond the duration 
of the project. First is the construction of a 
“blueprint” for the taxonomy—an effort that will 
be led by the author. The blueprint will specify 
the principles by which treatments are grouped 
in the final taxonomy. In principle, one could sort 
rehabilitation treatments into categories according 
to whether the treatment was provided by a 
woman, a man, or a robot; whether the treatment 
was conducted in the morning or the afternoon; 
or an infinite number of other dimensions. The 
development of the blueprint will be shaped by 
reviewing published literature on a wide range 
of rehabilitation treatments and services, paying 
particular attention to overt or covert “treatment 
theory,” since treatment theory proposes the 
mechanism by which a treatment works. Thus, 
to the extent possible, the boundaries between 
treatment taxonomy categories should reflect the 
active ingredients of the treatments as opposed to 
dimensions that don’t bear on how the treatment 
will be used or how effective it will be. Upon 
completion of the blueprint, a multidisciplinary 
stakeholder conference will be held to review and 
critique the blueprint.
After the investigators obtain feedback from 
rehabilitation professionals and consumer 
advocacy groups, the blueprint will be tested by 
using it to construct treatment taxonomies in 
two focused areas: treatments to improve gait 
and mobility for individuals with neurologic 
impairments; and treatments to ameliorate 
executive function deficits in individuals 
with brain injury. The choice of exemplars is 
relatively arbitrary and reflects a desire to assess 
the blueprint’s capacity to guide organization 
of a more cognitive vs. more motor domain, 
and to use domains with which the research 
team is particularly knowledgeable. Taxonomy 
development in these two treatment areas may 
suggest further refinements of the blueprint itself, 
with the goal that, by the end of the five-year 
project, a relatively enduring blueprint will be 
published that can support further taxonomic 
development in many additional treatment 
areas. In the final stages of the project, the two 
taxonomies discussed above and the revised 
blueprint will be reviewed and critiqued by 
external stakeholders, and plans made to continue 
further development of a useful treatment 
taxonomy for rehabilitation.  
John Whyte, MD, PhD
Director 
Moss Rehabilitation Research Institute
For more information contact the author at:  
JWhyte@einstein.edu. 
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On December 15, 2008, former Congressman 
Dick Gephardt facilitated a program that featured 
keynote speaker Governor Edward G. Rendell 
to discuss the future of medical innovation in 
the United States. The discussion focused, in 
particular, on the greater Philadelphia area in 
the context of the current economic downturn. 
In addition to the keynote, two expert panels 
highlighted obstacles to innovation as well as 
potential solutions. Panelists included:
•   Dennis M. “Mickey” Flynn, President of 
Pennsylvania BIO 
•   Glen N. Gaulton, PhD, Executive Vice Dean, 
Chief Scientific Officer at The University of 
Pennsylvania School of Medicine 
•   Brenda Gavin, DVM, MBA, Founding Partner 
of Quaker BioVentures 
•   Paul Howard, PhD, Senior Fellow and Director 
of the Center for Medical Progress at the 
Manhattan Institute for Policy Research 
•   Russel Kaufman, MD, President and CEO of 
the Wistar Institute 
•   Alan Leshner, PhD, CEO of the American 
Association for the Advancement of Science 
•   Joseph M. Mahady, President of Wyeth 
Pharmaceuticals and Senior Vice President  
at Wyeth 
•   Thomas Morr, President and CEO of Select 
Greater Philadelphia 
•   David B. Nash, MD, MBA, Dean of the 
Jefferson School of Population Health at  
Thomas Jefferson University 
•   Barbara S. Schilberg, Managing Director and 
Chief Executive Officer of BioAdvance 
•   The Honorable Joe Sestak (D-PA), U.S. House 
of Representatives 
•   George Wohlreich, MD, Director and CEO of 
the College of Physicians of Philadelphia 
The Greater Philadelphia area is a hub for medical 
innovation activities, with a strong biotechnology 
sector and numerous academic institutions  
with nationally recognized programs in the  
life sciences. According to a 2005 Milken  
Institute study1, the medical innovation industry 
in Greater Philadelphia encompasses 11.4 percent 
of all employment in the region, 12.8 percent  
of total earnings, and 7.1 percent of gross  
metro product. 
Panelists drew attention to several key  
issues the region faces in capitalizing on these  
resources, with a focus on research and 
development, financing, and education.  
With respect to research and development, 
effective technology transfer and translational 
research will allow medical innovation to  
evolve along the continuum from basic science 
research to clinical care at the bedside. In  
order for this to occur, partnerships between 
academia and industry are essential. Funding 
challenges include aligning incentives for  
research and development, incentives for 
investigators to pursue basic science research,  
and defining the roles of public and private 
funding sources. Finally, panelists indicated  
that high quality education in the sciences 
must begin in elementary school and continue 
throughout higher education. Graduate  
programs in the sciences must be able to  
recruit young investigators and retain them 
following graduation.  
The event was co-hosted by America’s 
biopharmaceutical companies, Pennsylvania BIO, 
BioAdvance and Select Greater Philadelphia.   
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School of Population Health Presentations
Goldfarb NI, Cole J, and Whitesell E. Key 
strategies for effective educational grant writing. 
Presented at: The 33rd  Annual Alliance for CME 
Conference. San Francisco, CA, January 30, 2009. 
Gottlieb D,  Friedman DA, Evans RA, Yuen E, 
Abdur-Razzaq Miller, IM. Religious perspectives 
on aging. Panel presentation at: Coming of Age 
presents Boomervision!® Philadelphia, PA, 
February 19, 2009. 
Reifsnyder J, Richardson D. Continuity of 
care for persons diagnosed with Alzheimer’s 
disease. Paper presentation at: The 61st Annual 
Meeting of the Gerontological Society of America. 
National Harbor, MD, November 22, 2008. 
Reville B, Reifsnyder J, Toner R, and Parks S. 
Hospital-based palliative care consultation:  
An opportunity to improve care for dementia. 
Paper presentation at: The 61st Annual Scientific 
Meeting of the Gerontological Society of America. 
National Harbor, MD, November 22, 2008. 
Reifsnyder J. Putting ethics in your toolbox: 
Managing dilemmas in end of life care. Podium 
presentation at: The New Jersey Hospice and  
Palliative Care Organization Annual Meeting, 
Eatontown, NJ, November 13, 2008. 
Safarty M. Tools for improving breast cancer 
screening rates. Presented at: Saving Lives in 
Brooklyn, Symposium on Breast Cancer. SUNY 
Downstate, Wellpoint, and the American Cancer 
Society. Brooklyn, NY, November 11, 2008.
Safarty M. Multiple chronic conditions: Health 
care delivery and public health. Presented at:  
Office of Population Health and Science,  
Department of Health & Human Services,  
Washington, DC, November 21, 2008.
Simmons R. Designing a cultural humility 
and competence online and in-person course for  
public health and health education practitioners. 
Presented at: The Society for Public Health  
Education (SOPHE) Annual Meeting, San Diego, 
CA, October 24, 2008.
Simmons R. Introducing public health 
informatics into a new MPH program.  
Presented at: The American Public Health  
Association (APHA) Annual Meeting,  
San Diego, CA, October 28, 2008,
Simmons R. Developing a leadership mindset 
(and skills) for health education.Presented at:  
The National Capital Chapter of the Society for 
Public Health Education (SOPHE), Rockville, MD, 
November 15, 2008.
Yaskin JC. Summit: The evidence base for 
effectiveness of obesity management progams— 
A comprehensive overview. Panelist at: 3rd  
Annual Obesity Congress: Implementing Wellness 
Initiatives and Promoting Health Behavior,  
Washington, DC, November 20, 2008. 
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